Why are these major media organizations citing BCC data?

consumer reports
The Economist
bbc news

Industrial Strength Research Reports - Reliable Data & Expert Analyses

Primary Sources in All Reports - U.S. Based Editorial Team & Client Support

  • This BCC Research report studies the role of paints and coatings in providing color and protection, explains the technology, highlights the innovation behind coatings development and production, and provides a market overview, analyzing major market trends both in terms of region and application segment. Forecast provided through 2021.

    Chemicals - September 2016
  • This BCC Research report measures, forecasts and segments the global magnetic resonance imaging (MRI) systems market by type of structure, field strength, application, technique, and region. Forecasts included from 2016 through 2021.

    Healthcare - September 2016
  • This BCC Research report provides analyses of emerging technologies and devices within the medical devices and diagnostics market. This includes information about new emerging technologies, medical devices, market players, issues and trends, and other information affecting the medical device and diagnostics industry. Forecast provided from 2016 through 2021.

    Healthcare - September 2016
  • This BCC Research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. Forecast included through 2021.

    Healthcare - September 2016
  • This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021.

    Pharmaceuticals - September 2016
  • This BCC Research report provides the recent advances and trends in manufacturing, applications, technologies, and global and regional markets for rigid transparent plastics. Forecast trends and sales in these markets are included through 2021.

    Plastics - September 2016
  • This BCC Research report is an analysis of the Raman spectroscopy market which includes factors currently driving and restraining the growth of the market, as well as factors impacting the future of the industry. Forecasts provided from 2016 through 2021.

    Instrumentation And Sensors - September 2016

  • Bugs are Winning: Time is Running out to Beat Antimicrobial Resistance Antimicrobial resistance (AMR) is jeopardizing human and animal health, as well as sustainable food production and development. AMR—the resistance of bacteria, viruses, fungi, and parasites to medicines—claims the lives of roughly 700,000 people each year. A recent Review on Antimicrobial Resistance, chaired by Jim O’Neill, estimated that without effective global action, the rise of AMR could claim 10 million lives globally each year by 2050 and result in a cumulative loss in global output of USD 100 trillion. The World Bank estimates that drug-resistant infections have the potential to cause at least as much economic damage as the 2008 financial crisis.
  • Sharply Rising Prevalence of Diabetes Driving Growth in Global Markets The worldwide prevalence of type 2 diabetes is reaching epidemic proportions. According to the International Diabetes Federation and other professional bodies, the global population of adults with diabetes (types 1 and 2) was approximately 415 million in 2015; that number is expected to rise to 642 million people by 2040. This trend is of grave concern to patients, healthcare providers, and governments. In addition to the direct burden of managing the disease, common and often catastrophic complications include cardiovascular disease, peripheral neuropathy, and blindness. Prompt diagnosis and effective treatment of diabetes are essential priorities for healthcare agencies and governments. The economic consequences of diabetes are also vast.
  • 2-D Nanomaterial Outperforms Graphene in EMI Shielding Since the beginning of the universe, electromagnetic radiation has been with us. But in recent decades, both the progression of technology and proliferation of electronics have contributed to a dramatic increase in electromagnetic interference (EMI).
  • Pharma Thinks Beyond the Pill: Connected Devices are a Smart Strategy MedCrypt, a medical device software security company, just announced the closing of $750,000 in seed round financing. With patient data increasingly at risk, the FDA has called for device manufacturers to strengthen their software security. This mandate creates big opportunities for companies like MedCrypt, which works with manufacturers to prevent unauthorized access and use of their medical devices. The worst-case scenario was illustrated in MedCrypt’s press release.
  • App Senses Flat Suds Flat beer is the scourge of beer drinkers, homebrewers, craft brewers and beer corporations alike. No one likes a flat-tasting beer.
  • New Thinner, Flatter Lens May Revolutionize Optics Researchers have invented a flat lens composed of paint whitener on a sliver of glass that may revolutionize optics. They claim the ultra-thin flat—or planar—lens works efficiently within the visible spectrum of light, covering the entire range of colors from red to blue. The discovery should lead the way to lighter, less-bulky cameras, telescopes, and cell phones, say the researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).
  • Mylan’s EpiPen is Just the Latest Contributor to Drug-Pricing Debate There’s a constant grumbling in the background when it comes to the prices of pharmaceuticals. Treatments for oncology and the hepatitis C virus are widely cited as among the most expensive medications. So, too, are certain therapies for orphan indications. The latest example to evoke widespread criticism is that of Mylan NV’s EpiPen device for treatment of severe allergic reactions. The EpiPen’s price has soared more than 400% since Mylan acquired the product in 2007, to more than $600 now, sparking outrage from patients, consumers, and politicians.
  • Do Orphan Drugs Significantly Contribute to Healthcare Spending? A new analysis finds that growing concerns about spending on prescription drugs that treat rare diseases are not justified. Researchers at IMS Health and Celgene Corporation analyzed US pharmaceutical spending from 2007 to 2013 on more than 300 drugs that had orphan approval under the 1983 Orphan Drug Act, which has long been considered a success for encouraging the production of hundreds of drugs for rare diseases.
  • Swedish Study Calls Out Software Flaws in fMRI Results Software packages that analyze the results of functional magnetic resonance imaging (fMRI) contain flaws that showed false brain activity on 60 percent of images, claim Swedish researchers. A reasonable percentage is five.

product catalog
BCC Library Video